Cross-Sector entity

Dr. Heinz Schimmelbusch

Person
5

All 1 tracked stories fall under one category: markets. AMG Critical Materials N.V. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Dr. Heinz Schimmelbusch appears in 1 tracked Cross-Sector story from August 24, 2026.

1 verified story tracked

Last mentioned: Aug 24, 2026

Entity pulse

Recent coverage · Dr. Heinz Schimmelbusch

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Dr. Heinz Schimmelbusch

All 1 tracked stories fall under one category: markets. AMG Critical Materials N.V. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Dr. Heinz Schimmelbusch appears in 1 tracked Cross-Sector story from August 24, 2026. The tracked stories average 2 original sources each.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Dr. Heinz Schimmelbusch. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. AMG announces Frankfurt secondary listing plan

    AMG Critical Materials N.V. says it will apply to list its shares on the Frankfurt Stock Exchange, with effectiveness expected in the course of 2026 and no new shares to be issued.

  2. Targeted effective date for Frankfurt listing

    AMG states the secondary listing is expected to become effective during 2026, complementing its primary Euronext Amsterdam listing.

Stories mentioning Dr. Heinz Schimmelbusch 1